Why Clarix for Sports Medicine Specialists?

Developed by pioneers in the field of regenerative medicine, CLARIX cryopreserved umbilical cord allograft delivers the innate properties of amniotic tissue to facilitate the healing process across a range of surgical specialties.

With CLARIX, you’re able to transplant the innate biology to the surgical site, thus supporting a more structured healing environment, helping to manage regenerative healing, and facilitating your patient’s functional recovery.

  • Leap Into Functional Recovery

    Learn more about how Amniox is harnessing the unique power of human birth tissue through the CLARIX family of products by downloading the product brochure. Fill out the form below to receive a copy:
  • By clicking the button below, I declare that I am a licensed health care professional or staff member. I also agree to receive marketing communications from Amniox. I am aware that I can unsubscribe at any time.
  • This field is for validation purposes and should be left unchanged.

Regenerative Medicine, Backed by Research

Our extensive research allows us to preserve and deliver the most functional allograft for your needs.

600K

Transplants

380

Clinical Publications

35Y

Research & Development

Facilitates Healing Across a Wide Range of Surgical Specialties

Supports decreased wound dehiscence and scar tissue formation to facilitate expedited wound healing and functional recovery16-24

 

Aids in reducing adhesion formation, and facilitates restoration of range of motion after tendon repair surgery and other soft tissue procedures17,23

 

UP TO 10X THICKER than amniotic membrane,25,26 which may increase longevity in the surgical site

 

Leap Into The Future of Functional Recovery With Clarix Family of Products

The Amniox family of cryopreserved umbilical cord allografts help deliver the innate properties of human birth tissue to wound environments.1

A wide range of adjunct therapies for the management of regenerative healing and functional recovery of surgical, acute and chronic wounds.

Learn more about the platform technology behind the CLARIX family of products by clicking the link below to download the product brochure.

References
Tseng SC. Invest Ophthalmol Vis Sci. 2016;57(5):ORSFh1‐ORSFh8.
Caputo WJ, Vaquero C, Monterosa A, et al. Wound Repair Regen. 2016;24(5):885-893.
Couture M. Wounds. 2016;28(7):217-25.
Marston WA, Lantis JC 2nd, Wu SC, et al. Wound Repair Regen. 2019;27(6):680-86.
Marston WA, Lantis JC 2nd, Wu SC, et al. Wound Repair Regen. 2020. Online ahead of print.
Raphael A. J Wound Care. 2016;25(Sup7):S10-17.
Raphael A, Gonzales J. J Wound Care. 2017;26(Sup10):S38-44.
Bemenderfer TB, Anderson RB, Odum SM, Davis WH. J Foot Ankle Surg. 2019;58(1):97-102.
DeMill SL, Granata JD, Berlet GC, et al. Surgical Technol Int. 2014;25:257-61.
Ellington J, Ferguson C. Surg Technol Int. 2014;25:63-67.
Garras D, Scott R. AOFAS Annual Meeting 2017.
Hanselman AE, Tidwell J, Santrock R. Foot Ankle Int. 2015;Feb;36(2):151-8.
Stewart CM. SunKrist J Trauma Emerg Med Acute Care. 2019;1(1):1-6.
Swan J. Surg Technol Int. 2014;25:73‐78.
Warner M, Lasyone L. Surg Technol Int. 2014;25:251-5.
Bemenderfer TB, Anderson RB, Odum SM, Davis WH. Effects of Cryopreserved Amniotic Membrane-Umbilical Cord Allograft on Total Ankle Arthroplasty Wound Healing. J Foot Ankle Surg. 2019;58(1):97-102.
DeMill SL, Granata JD, Berlet GC, et al. Safety Analysis of Cryopreserved Amniotic Membrane/Umbilical Cord Tissue in Foot and Ankle Surgery: A Consecutive Case Series of 124 Patients. Surgical Technol Int. 2014;25:257-61.
Ellington J, Ferguson C. The use of amniotic membrane/umbilical cord in first metatarsophalangeal joint cheilectomy: a comparative bilateral case study. Surg Technol Int. 2014;25:63-67.
Garras D, Scott R. Particulate Umbilical Cord/Amniotic Membrane for the Treatment of Plantar Fasciitis. AOFAS Annual Meeting 2017.
Hanselman AE, Tidwell J, Santrock R. Cryopreserved Human Amniotic Membrane Injection for Plantar Fasciitis: A Randomized, Controlled, Double-Blind Pilot Study. Foot Ankle Int. 2015 Feb;36(2):151-8.
Stewart CM. The Use of Cryopreserved Umbilical Cord in Open Reduction and Internal Fixation of Calcaneal Fractures. SunKrist J Trauma Emerg Med Acute Care. 2019;1(1):1-6.
Swan J. Use of Cryopreserved, Particulate Human Amniotic Membrane and Umbilical Cord (AM/UC) Tissue: A Case Series Study for Application in the Healing of Chronic Wounds. Surg Technol Int. 2014;25:73‐78.
Warner M, Lasyone L. An Open-label, Single-center, Retrospective Study of Cryopreserved Amniotic Membrane and Umbilical Cord Tissue as an Adjunct for Foot and Ankle Surgery. Surg Technol Int. 2014;25:251-5.
Papanna R, Moise KJ Jr, Mann LK, et al. Cryopreserved Human Umbilical Cord Patch for In-Utero Spina Bifida Repair. Ultrasound Obstet Gynecol. 2016;47(2):168-76.
Cooke M, Tan EK, Mandrycky C, He H, O’Connell J, Tseng SC. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissue. J Wound Care. 2014;23(10):465-476.
Tan EK, Cooke M, Mandrycky C, et al. Structural and biological comparison of cryopreserved and fresh amniotic membrane tissues. J Biomaterial T Eng. 2014;4:379-388.